Introduction to Helius Medical Technologies
Helius Medical Technologies, Inc. is a pioneering neurotechnology company focused on developing innovative therapeutic solutions aimed at addressing neurogenic balance and gait disorders. Known for its commitment to enhancing patient outcomes, Helius has made significant strides in the medical device sector by offering cutting-edge neuromodulation technologies.
Participation in The ThinkEquity Conference
On October 30, 2024, Helius Medical Technologies will participate in The ThinkEquity Conference, held at the prestigious Mandarin Oriental Hotel in New York. This prominent event serves as a convergence point for institutional investors, corporate leaders, and industry experts to discuss and explore financial strategies and groundbreaking innovations.
Presentation Schedule
The management team will present at 4:30 PM ET, showcasing the company's advancements and future goals. Moreover, they will engage in one-on-one meetings with potential investors throughout the day, providing a unique opportunity for personalized discussions and insights into the company's operations.
About The ThinkEquity Conference
The ThinkEquity Conference is a well-regarded investment banking event organized by seasoned professionals with extensive experience in capital financing. The event boasts a rich history of over 70 company presentations, attracting more than 700 attendees and facilitating over 500 one-on-one meetings. This creates a dynamic platform for networking and collaboration, essential for the growth of businesses and investors alike.
Connecting with Investors
For investors interested in attending or scheduling one-on-one meetings with Helius Medical Technologies, registration is straightforward. The event presents a valuable opportunity for investors to connect intimately with the company’s leaders and gain deeper insights into their innovative approaches.
Helius Medical’s Innovative Solutions
Helius Medical Technologies stands at the forefront of neurotechnology, focusing on addressing neurologic deficits through an innovative oral technology platform. This platform empowers the brain, enabling it to engage physiological compensatory mechanisms and promote neuroplasticity. These advancements are designed to significantly improve the quality of life for individuals coping with various neurologic conditions.
Flagship Product: Portable Neuromodulation Stimulator
The company's flagship product, the Portable Neuromodulation Stimulator, is a testament to Helius's commitment to delivering effective neurological therapies. This device has shown promising results in clinical settings, providing users with an accessible means of managing their symptoms and enhancing their overall well-being.
Looking Ahead
As Helius Medical Technologies endeavors to expand its reach and impact in the neurotech landscape, the upcoming ThinkEquity Conference serves as a vital platform for establishing meaningful connections and showcasing their pioneering solutions. Investors can anticipate insightful discussions and a comprehensive overview of the company’s current trajectory and future aspirations.
Contact Information for Investors
Helius Medical Technologies values transparency and communication with its stakeholders. For any inquiries regarding the company or its innovative technologies, interested parties can reach out through their investor relations contact: Philip Trip Taylor at Gilmartin Group. The company encourages investors to get in touch to explore collaborative opportunities.
Frequently Asked Questions
What is the main focus of Helius Medical Technologies?
Helius Medical Technologies concentrates on developing therapeutic technologies for balance and gait disorders resulting from neurological conditions.
When and where will the ThinkEquity Conference take place?
The ThinkEquity Conference is scheduled for October 30, 2024, at the Mandarin Oriental Hotel in New York.
How can investors participate in the conference?
Investors can register to attend the conference and schedule one-on-one meetings with Helius’s management teams for personalized discussions.
What is Helius Medical's flagship product?
The flagship product is the Portable Neuromodulation Stimulator, designed to help manage symptoms associated with neurological diseases.
How can investors get in touch with Helius Medical Technologies?
Investors can contact Philip Trip Taylor at Gilmartin Group for inquiries related to investment opportunities and company insights.
